SECTOR GUIDE · MANUFACTURING
Manufacturing. R&D claims, supply chain VAT.
The pattern we see
Manufacturing carries the most varied tax pattern of any sector we work with. Capital-heavy businesses use capital allowances heavily, which compresses CT in good years and creates surprising bills in years where investment slows. R&D claims (legitimately the most common in this sector) used to land within four to six weeks of filing and now take three months or more, creating a pure cashflow gap. And the supply chain runs on payment terms that almost always leave you paying suppliers before customers pay you, which means VAT gets reclaimed before output VAT comes in. Until it doesn't, and a bill lands.
The merged R&D scheme that came in for accounting periods starting from 1 April 2024 changed the cashflow maths. Most manufacturers no longer get the old 33% effective rate, the credit is taxable, and HMRC scrutiny has tightened. ERIS (Enhanced R&D Intensive Support) remains for loss-making R&D-intensive companies but the bar to qualify is high. The result for most manufacturers is a smaller credit, slower to land, and worth bridging with an R&D advance more often than before.
On the bills side, VAT in manufacturing is unusual because of supply chain length. A long lead time on raw materials means you reclaim input VAT in March on stock that doesn't sell until July. Some quarters you're a net reclaimer; some quarters you're a net payer with a six-figure liability. Plan facilities around the cycle, not around any single quarter.
Which products fit
Bill type, size, and lender appetite for this sector.
| Bill type | Likelihood | Typical size | Lender appetite |
|---|---|---|---|
| R&D | High | £50k–£500k advance | Specialist lenders strong on filed claims; pre-filing harder |
| VAT | High | £20k–£400k | Strong, longer terms (9–12 mo) common |
| CT | Medium | £25k–£600k | Strong with two clean filed years; capital allowance position matters |
| PAYE | Medium | £15k–£100k | Selective; preference for direct labour over agency-heavy |
Real example
A precision engineering firm in Yorkshire filed a £210,000 R&D claim in October 2025 for an accounting period that ended 31 December 2024. HMRC processing had stretched to 14 weeks. The firm had a £95,000 CT bill due 1 October and a VAT bill of £62,000 due 7 December. We arranged an R&D advance against the filed claim at 75% LTV (£157,000), which covered the CT bill, the VAT bill, and a stock buy ahead of a major order. HMRC paid the credit in mid-January and the advance settled in full from the payment.
Anonymised. Names, locations, and trading details changed. Numbers indicative.
Watch-outs
- R&D claims under the merged scheme face tighter HMRC scrutiny. Use a reputable adviser; weak claims attract enquiries that delay payouts further.
- Capital allowance super-deduction has ended; full expensing is the current regime for plant and machinery. Plan investment timing around when you actually need the deduction.
- Long supply chain means a single late shipment can flip a quarter from net reclaimer to net payer. Lender appetite drops fast if filings show this volatility uncontrolled.
- ERIS qualification is a binary test and the threshold matters. Some firms file as if they qualify and don't. Accept the regular rate rather than risk the enquiry.
Manufacturing bill on the horizon? We'll quote it.
Funded direct to HMRC. No cost to enquire.
Get a quote →